FDA Approves Firdapse for Rare Autoimmune Disorder

THURSDAY, Nov. 29, 2018 -- Firdapse (amifampridine) tablets have been approved by the U.S. Food and Drug Administration for adults with Lambert-Eaton myasthenic syndrome (LEMS). The drug is the first agency-sanctioned treatment for the autoimmune...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news